XML 84 R68.htm IDEA: XBRL DOCUMENT v3.6.0.2
Shareholders' Equity - Stock Option Activity (Details) - Stock options - 2012 Equity Incentive Plan - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]        
Options outstanding, beginning of period (in shares) 2,484,400 2,165,000 1,190,000  
Granted (in shares) 708,000 588,500 1,270,000  
Exercised (in shares) (196,000) (16,600) (28,750)  
Forfeited (in shares) (169,900) (252,500) (266,250)  
Options outstanding, end of period (in shares) 2,826,500 2,484,400 2,165,000 1,190,000
Share-based Compensation Arrangement by Share-based Payment Award, Weighted Average Exercise Price [Roll Forward]        
Options outstanding, weighted average exercise price, beginning balance (in dollars per share) $ 16.22 $ 16.17 $ 15.48  
Granted, weighted average exercise price (in dollars per share) 14.15 16.49 16.74  
Exercised, weighted average exercise price (in dollars per share) 16.18 15.16 15.00  
Forfeited, weighted average exercise price (in dollars per share) 16.38 16.57 15.88  
Options outstanding, weighted average exercise price, ending balance (in dollars per share) $ 15.69 $ 16.22 $ 16.17 $ 15.48
Share-based Compensation Arrangement by Share-based Payment Award, Intrinsic Value [Roll Forward]        
Options outstanding, intrinsic value, beginning of period $ 1,225 $ 1,890 $ 862  
Exercised, intrinsic value 790 19 74  
Options outstanding, intrinsic value, end of period $ 14,956 $ 1,225 $ 1,890 $ 862
Options outstanding, weighted average contractual life 7 years 7 months 6 days 8 years 7 days 8 years 9 months 18 days 9 years 3 months 18 days
Options exercisable at period end (in shares) 1,245,375      
Options exercisable at period end, weighted average exercise price (in dollars per share) $ 15.94      
Options exercisable at period end, weighted average contractual life 6 years 8 months 12 days      
Options exercisable at period end, intrinsic value $ 6,276